MedPath

An Age-Stratified Data Collection Study to Establish a Normative Database Using the 3D Optical Coherence Tomography 3D OCT-1000 Mark II

Withdrawn
Conditions
Healthy
Registration Number
NCT01027936
Lead Sponsor
Topcon Corporation
Brief Summary

To collect three dimensional retinal measurements of the optic disc and the macula lutea on healthy normal subjects using the 3D OCT-1000 Mark II for the purpose of developing a normative database that is stratified by age.

Detailed Description

Not available

Recruitment & Eligibility

Status
WITHDRAWN
Sex
All
Target Recruitment
180
Inclusion Criteria
  • Male and Females at least 18 years of age;
  • Must be a member of one of the 3 ethnic groups: Caucasian, Hispanic or African American. Asians, Eastern Indians, and Native Americans have been excluded from this study;
  • Signed, written informed consent obtained for the study;
  • BSCVA of 20/40 or better in both eyes;
  • Intraocular pressure (IOP) ≤ 21 mm Hg in both eyes.
Exclusion Criteria
  • Ocular disease;
  • Cataract on slit lamp exam with a corresponding loss of BSCVA worse than 20/25;
  • Corneal surface disruption precluding imaging;
  • Prior ocular surgery except uncomplicated phacoemulsification or strabismus surgery;
  • Prior corneal refractive surgery of any type;
  • Family history of glaucoma among first generation relatives;
  • Current history of an acute or chronic disease or illness that would confound the normative outcome(s) of the study;
  • Current use of systemic medications that may confound the outcome of the study;
  • Nystagmus or any other condition that would prevent a steady gaze during study tests or measurements;
  • Current history of inflammation or infection of the eye or eyelids; injury to the eye.

Study & Design

Study Type
OBSERVATIONAL
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
A normative dataset containing a statistical description of expected norms of retinal nerve fiber layer (RNFL) and macula lutea thickness, stratified by age.12 Months
Secondary Outcome Measures
NameTimeMethod

Trial Locations

Locations (6)

Durrie Vision

🇺🇸

Overland Park, Kansas, United States

Glaucoma Associates of New York

🇺🇸

New York, New York, United States

Shiley Eye Center UCSD

🇺🇸

La Jolla, California, United States

SUNY

🇺🇸

New York, New York, United States

Eye Institute/Medical College of WI

🇺🇸

Milwaukee, Wisconsin, United States

Vitreous-Retina-Macula Consultants of New York, P.C.

🇺🇸

New York, New York, United States

© Copyright 2025. All Rights Reserved by MedPath